Profiling and characterization of microRNAs responding to sodium butyrate treatment in A549 cells.

about

Profiling and characterization of microRNAs responding to sodium butyrate treatment in A549 cells.

Item

http://www.wikidata.org/entity/Q47787181

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Profiling and characterization ...... yrate treatment in A549 cells.

@en

Profiling and characterization ...... yrate treatment in A549 cells.

@nl

type

Item

label

Profiling and characterization ...... yrate treatment in A549 cells.

@en

Profiling and characterization ...... yrate treatment in A549 cells.

@nl

prefLabel

Profiling and characterization ...... yrate treatment in A549 cells.

@en

Profiling and characterization ...... yrate treatment in A549 cells.

@nl

P1476

Profiling and characterization ...... yrate treatment in A549 cells.

@en

P2093

Haoyu Chen

http://www.w3.org/2001/XMLSchema#string

Yingjie Cao

http://www.w3.org/2001/XMLSchema#string

P2860

MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma

A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer

Long Noncoding RNAs as Novel Biomarkers Have a Promising Future in Cancer Diagnostics

Butyrate, neuroepigenetics and the gut microbiome: Can a high fiber diet improve brain health?

Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.

MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence

Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells

Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma.

Chitosan nanoparticle-mediated delivery of miRNA-34a decreases prostate tumor growth in the bone and its expression induces non-canonical autophagy

Vancomycin treatment and butyrate supplementation modulate gut microbe composition and severity of neointimal hyperplasia after arterial injury.

P304

3563-3573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCB.26547

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Xiaoqiang Xiao

P577

2017-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29231270

http://www.w3.org/2001/XMLSchema#string

P921

microRNA